Abstract Submission Guidelines

CATEGORIES

The 12th Federation of Asian Small Animals Veterinary Association (12th FASAVA Congress) will be held 19 - 21 July 2024, at the Kuala Lumpur Convention Centre, Kuala Lumpur, Malaysia. The theme of the Congress is “Empowering Asia Pacific Veterinary Medicine in Companion Animal Practice towards Excellence with Integrity & Innovation”. The 12th FASAVA Scientific Committee now wishes to invite abstract for oral and poster presentations.

Please carefully read the Abstract Guideline below before submitting an abstract. Abstract can only be submitted electronically through the official Congress website.

Important Dates (GMT+8) (Malaysian Local Time)

Instruction to Authors

General rules for submission

Please read the submission rules before submitting an abstract.

1. Abstracts must be submitted online via the website only. Abstracts submitted by email will not be accepted.
2. Abstract stream: Choose ONE stream which best fits your abstract content.
   • Exotic Pet Medicine & Surgery
   • Internal Medicine & Imaging
   • One Health, Emerging Diseases and Zoonosis
   • Surgery, Anaesthesiology & Emergency Medicine
   • Others (Education, Alternative Medicine, Behaviour etc.)
3. Presentation Type: Abstracts may be submitted for either an Oral Communication, Poster presentation or no preference.
4. Abstract type: Abstracts can be classified as a Case Report or Clinical Research.
5. Abstracts must be received by Malaysian local time (GMT+8) of 31st March 2024. Abstracts received after the deadline will not be considered.
6. The same person may submit up to 2 abstracts as the presenting author.
7. Accepted abstracts will be published in the official congress proceedings.
8. Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees will be scheduled for presentation and included in the publication.
9. Abstracts must be submitted in British English. All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication.
10. Abstracts must be original and not have been published or presented at any other meeting before the FASAVA 2024 Congress. All research presented must comply with international standards pertaining to animal welfare, ethics, and data protection.
11. Contact information: official congress email address programme@fasava2024kualalumpur.com

Guidelines for abstract preparation submission

Before you begin, please prepare the following information:

1. Abstract stream – select the abstract topic per the list of streams from the dropdown menu.
2. Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words.
3. Presenting author's contact details:
   • Full first and family name(s)
   • Email address
   • Affiliation details: department, institution/hospital, city, state (if relevant), country
   • Phone number
4. Author and co-authors' details
5. Abstract format:
   • File name: For file name, please indicate your abstract stream (eg.Exotic Pet Medicine & Surgery, Internal Medicine & Imaging, One Health, Emerging Diseases and Zoonosis, Surgery, Anaesthesiology & Emergency Medicine). Then add the Authors Name followed by the title of your paper
     Example : ExoticPetMedicine_AuthorName_Title of paper
   • The abstract title : (The format of the abstract title is in capital letters, the font is Arial, Font size 11pt, Bold and Centered)
   • Presenting author and co authors : (The font is Arial, Font size 11pt)
   • Affiliation details (Format is Arial, Font Size 10pt and Italic)
   • The paper must be typed in single column format on international standard A4 paper with margins of 2.54cm
   • The main text: (The font is Arial, Font size 11 pt, single-spaced and justified)
6. Abstract text - limited to 300 words from introduction to conclusion. Abstract body should include the following sections:
   • CLINICAL RESEARCH
     • Introduction
       The goal of the introduction is to stimulate the reader to the relevance of the work. It should start with a short background of the study in 1-2 sentences. Then it should highlight what the study is about and the importance of the study.
     • Objectives
       The objectives of the study should be stated in a clear and concise manner.
     • Methods
       This should include:
       • Type of study - retrospective study, randomised study, case-control study, blinded, etc.
       • Species, number of animals used.
       • Samples collected and analysed.
     • Results
       The authors should briefly summarise the main results of the study.
     • Conclusion
       The conclusion must be supported by the results. It is written in a short, clear, and objective manner. Hypotheses or scenarios other than those investigated should not be presented. If word count allows the implication of the study for future work or clinical practice can also be mentioned.
   • CASE REPORT
     • Introduction
       Describe the context of the case and explain its relevance and importance. Describe whether the case is unique. If not, does the case have an unusual diagnosis, prognosis, therapy, or harm? Is the case an unusual presentation of a common condition? Or an unusual complication of a disease or management? Describe the instructive or teaching points that add value to this case. Does it demonstrate a cost-effective approach to management or an alternative diagnostic/treatment strategy? Does it increase awareness of a rare condition?
     • Case description
       Report the case in sequence. Describe the signalment, history, examination, investigations and treatments adequately. Have all available therapeutic options been considered? Are outcomes related to treatments? Include the patient's progress and outcome.
     • Discussion & Conclusion
       Discuss the rationale for decisions that were made and the lesson from the case. Describe how this case is different from those previously reported. Does it challenge prevailing wisdom? In the future, could things be done differently in a similar case?
7. Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
8. Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
9. Submissions may not contain patient names or other identifying information.
10. After the submission deadline, abstracts cannot be modified or corrected. Please do not submit multiple copies of the same abstract.
11. You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.

Abstract submitters’ declaration

During abstract submission, you will be asked to confirm that you agree to the following:

1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified however minor editing may be requested by the scientific committee if necessary.
2. Submission of the abstract constitutes my consent to publication in the congress proceedings.
3. As the Abstract Submitter, I represent all the authors in correspondence with the congress secretariat regarding my abstract. I have full rights and responsibility for the content published in the proceedings.
4. The publication of the abstract does not infringe any third-party rights including, but not limited to, intellectual property rights.
5. I understand that the presenting author must be a registered participant.
6. The Organisers reserve the right to remove an abstract that does not comply with the above from any publication.
7. I understand that I must select a specific topic for my abstract allocation. Although the Committee will work hard to honour this selection, this cannot be guaranteed. The Committee reserves the right to change the Topic under which the abstract was originally submitted.
8. I hereby confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.